Immunomedics Inc (NASDAQ:IMMU)

16.50
Delayed Data
As of Apr 20
 -0.20 / -1.20%
Today’s Change
5.00
Today|||52-Week Range
18.93
+2.10%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close16.70
Today’s open16.64
Day’s range16.34 - 16.79
Volume1,143,272
Average volume (3 months)2,389,580
Market cap$2.9B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-137.10%
Earnings growth (this year)+28.12%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-4.39%
P/E ratioNM
Price/Sales298.60
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp-0.74-1.31%
--Quidel Corp-0.27-0.60%
MYGNMyriad Genetics Inc-0.14-0.48%
----
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.1M
Annual profit (last year)-$153.2M
Net profit margin-4,956.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Michael Pehl
Chief Financial Officer &
Vice President
Michael R. Garone
Corporate headquarters
Morris Plains, New Jersey

Forecasts